Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

4.27
-0.3600-7.78%
Volume:107.55K
Turnover:476.23K
Market Cap:9.19M
PE:-0.14
High:4.54
Open:4.54
Low:4.21
Close:4.63
52wk High:100.80
52wk Low:2.77
Shares:2.15M
Float Shares:1.30M
Volume Ratio:0.81
T/O Rate:8.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-30.9580
EPS(LYR):-30.9580
ROE:-27725.96%
ROA:-30.41%
PB:-176.78
PE(LYR):-0.14

Loading ...

HCW Biologics Stock Rockets 55% on Cancer Treatment Data

TIPRANKS
·
Aug 26

Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July

Benzinga
·
Aug 26

HCW Biologics Inc. (HCWB.US) Surges Nearly 70% Following Launch of Next-Generation Cancer Immunotherapy Platform

Stock News
·
Aug 25

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform

Benzinga_recent_news
·
Aug 25

HCW Biologics develops second-generation immune checkpoint inhibitor

TIPRANKS
·
Aug 25

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

GlobeNewswire
·
Aug 25

HCW Biologics Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Aug 20

HCW Biologics Inc. Faces Potential Nasdaq Delisting After Non-Compliance with Equity Rule

Reuters
·
Aug 20

BRIEF-HCW Biologics Says Substantial Doubt Exists Regarding Ability To Continue As Going Concern For At Least 12 Months

Reuters
·
Aug 19

HCW Biologics Q2 EPS $(6.79) Misses $1.80 Estimate, Sales $6.550K Miss $7.000M Estimate

Benzinga
·
Aug 19

HCW Biologics- as of June 30, Believes Substantial Doubt Exists Regarding Ability to Continue as Going Concern for at Least 12 Months

THOMSON REUTERS
·
Aug 19

Press Release: HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

Dow Jones
·
Aug 19

HCW Biologics Inc. Delays Q2 2025 Financial Report Citing Preparation Challenges

Reuters
·
Aug 15

HCW Biologics Inc. Announces Amended Equity Purchase Agreement with Square Gate Capital, Enabling Flexible $20M Stock Sales

Reuters
·
Aug 15

HCW Biologics Reports Q2 2025 Revenue Drop to $6,550 from $618,854 Previous Year; Completes $5M Equity Offering

Reuters
·
Aug 15

Stocks to Watch: Block, Barnes & Noble Education, HCW Biologics

Dow Jones
·
Jul 19

HCW Biologics Inc. Secures $7 Million License Agreement with WY Biotech

Reuters
·
Jul 19

HCW Biologics Advances Alopecia Areata Treatment with New Phase 1 Study

TIPRANKS
·
Jul 12

HCW Biologics Inc. Regains Full Compliance with Nasdaq Listing Requirements

Reuters
·
Jun 26

HCW Biologics Board Member Resignation and Director Elections

TIPRANKS
·
Jun 24